Vasoprotective effects of an endothelin receptor antagonist in ovariectomized female rats

Life Sciences

Volumn 118, Issue 2, 2014, Pages 379-385

  Kitada, Kento ^a,b   Yui, Nozomi ^a   Mori, Tatsuhiko ^a   Ohkita, Mamoru ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Balloon injury; Endothelin 1; Estrogen; Neointimal formation

Indexed keywords

2 BUTYL 7 [2 (2 CARBOXYPROPYL) 4 METHOXYPHENYL] 5 (3,4 METHYLENEDIOXYPHENYL)CYCLOPENTENO[1,2 B]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ESTRADIOL; FULVESTRANT; PROTECTIVE AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY; CAROTID ARTERY INJURY; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; MONOTHERAPY; NEOINTIMA; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; RAT; TREATMENT DURATION; ANIMAL; DRUG COMBINATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; CAROTID ARTERIES; DRUG THERAPY, COMBINATION; ENDOTHELIN RECEPTOR ANTAGONISTS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; NADP; NEOINTIMA; OVARIECTOMY; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 84942576968     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.01.009     Document Type: Article

References (44)

1. Bakir, S., Mori, T., Durand, J., Chen, Y.F., Thompson, J.A., Oparil, S., Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 101 (2000), 2342–2344.
2. Bernelot Moens, S.J., Schnitzler, G.R., Nickerson, M., Guo, H., Ueda, K., Lu, Q., et al. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation 126 (2012), 1993–2004.
3. Best, P.J., Berger, P.B., Miller, V.M., Lerman, A., The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128 (1998), 285–288.
4. Bohm, F., Pernow, J., The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76 (2007), 8–18.
5. Chen, S.J., Li, H., Durand, J., Oparil, S., Chen, Y.F., Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93 (1996), 577–584.
6. Douglas, S.A., Louden, C., Vickery-Clark, L.M., Storer, B.L., Hart, T., Feuerstein, G.Z., et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 75 (1994), 190–197.
7. Dubey, R.K., Jackson, E.K., Keller, P.J., Imthurn, B., Rosselli, M., Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37 (2001), 640–644.
8. Farhat, M.Y., Lavigne, M.C., Ramwell, P.W., The vascular protective effects of estrogen. FASEB J 10 (1996), 615–624.
9. Florian, M., Freiman, A., Magder, S., Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 69 (2004), 779–787.
10. Grady, D., Rubin, S.M., Petitti, D.B., Fox, C.S., Black, D., Ettinger, B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 (1992), 1016–1037.
11. Hernandez Schulman, I., Zhou, M.S., Raij, L., Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans. Hypertension 49 (2007), 270–271.
12. Huckle, W.R., Drag, M.D., Acker, W.R., Powers, M., McFall, R.C., Holder, D.J., et al. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation 93 (1996), 1009–1019.
13. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA 280 (1998), 605–613.
14. Kawanishi, H., Hasegawa, Y., Nakano, D., Ohkita, M., Takaoka, M., Ohno, Y., et al. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Clin Exp Pharmacol Physiol 34 (2007), 280–285.
15. Kirchengast, M., Munter, K., Endothelin and restenosis. Cardiovasc Res 39 (1998), 550–555.
16. Kirkby, N.S., Duthie, K.M., Miller, E., Kotelevtsev, Y.V., Bagnall, A.J., Webb, D.J., et al. Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury. Cardiovasc Res 95 (2012), 19–28.
17. B receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery. J Pharmacol Exp Ther 331 (2009), 998–1004.
18. B receptor is involved in sex differences in the development of balloon injury-induced neointimal formation. J Pharmacol Exp Ther 336 (2011), 533–539.
19. Kitada, K., Ohkita, M., Matsumura, Y., Pathological importance of the endothelin-1/ET(B) receptor system on vascular diseases. Cardiol Res Pract, 2014 [in press].
20. Kobori, H., Nangaku, M., Navar, L.G., Nishiyama, A., The intrarenal renin–angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59 (2007), 251–287.
21. Kurumazuka, D., Mori, T., Matsumoto, N., Shirakawa, H., Kimura, S., Nakano, D., et al. Gender difference of atorvastatin's vasoprotective effect in balloon-injured rat carotid arteries. Eur J Pharmacol 553 (2006), 263–268.
22. Lekontseva, O., Chakrabarti, S., Davidge, S.T., Endothelin in the female vasculature: a role in aging?. Am J Physiol Regul Integr Comp Physiol 298 (2010), R509–R516.
23. Little, P.J., Ivey, M.E., Osman, N., Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr Vasc Pharmacol 6 (2008), 195–203.
24. 1 receptor blocker on neointima formation. Hypertension 40 (2002), 451–457 [discussion 48–50].
25. Maeda, S., Tanabe, T., Miyauchi, T., Otsuki, T., Sugawara, J., Iemitsu, M., et al. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 95 (2003), 336–341.
26. Mahendru, A.A., Morris, E., Cardiovascular disease in menopause: does the obstetric history have any bearing?. Menopause Int 19 (2013), 115–120.
27. Maranon, R., Reckelhoff, J.F., Sex and gender differences in control of blood pressure. Clin Sci (Lond) 125 (2013), 311–318.
28. Miller, A.P., Chen, Y.F., Xing, D., Feng, W., Oparil, S., Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 42 (2003), 657–663.
29. Miyauchi, T., Yanagisawa, M., Iida, K., Ajisaka, R., Suzuki, N., Fujino, M., et al. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 123 (1992), 1092–1093.
30. Murakoshi, N., Miyauchi, T., Kakinuma, Y., Ohuchi, T., Goto, K., Yanagisawa, M., et al. Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106 (2002), 1991–1998.
31. Nakashima, H., Suzuki, H., Ohtsu, H., Chao, J.Y., Utsunomiya, H., Frank, G.D., et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 4 (2006), 67–78.
32. Ohkita, M., Tawa, M., Kitada, K., Matsumura, Y., Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci 119 (2012), 302–313.
33. Pare, G., Krust, A., Karas, R.H., Dupont, S., Aronovitz, M., Chambon, P., et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 90 (2002), 1087–1092.
34. Pedersen, S.H., Nielsen, L.B., Mortensen, A., Nilas, L., Ottesen, B., Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause 15 (2008), 503–510.
35. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 (2002), 321–333.
36. Takahashi, M., The role of endothelin-1 in vascular remodeling in vivo. Cardiovasc Res 71 (2006), 4–5.
37. Taniyama, Y., Griendling, K.K., Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003), 1075–1081.
38. Tolbert, T., Thompson, J.A., Bouchard, P., Oparil, S., Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 104 (2001), 2740–2745.
39. Tostes, R.C., Fortes, Z.B., Callera, G.E., Montezano, A.C., Touyz, R.M., Webb, R.C., et al. Endothelin, sex and hypertension. Clin Sci (Lond) 114 (2008), 85–97.
40. 1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 45 (2005), 545–551.
41. von Lueder, T.G., Krum, H., RAAS inhibitors and cardiovascular protection in large scale trials. Cardiovasc Drugs Ther 27 (2013), 171–179.
42. Walsh, B.W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., Sacks, F.M., Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325 (1991), 1196–1204.
43. Wang, X., Douglas, S.A., Louden, C., Vickery-Clark, L.M., Feuerstein, G.Z., Ohlstein, E.H., Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ Res 78 (1996), 322–328.
44. Zalba, G., Beloqui, O., San Jose, G., Moreno, M.U., Fortuno, A., Diez, J., NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 25 (2005), 1452–1457.